Individualised Versus Conventional Balloon Dilation for TIPS : Hepatic Encephalopathy in a Propensity‐Matched Before‐After Study

BACKGROUND AND AIMS: Hepatic encephalopathy (HE) is a major complication of transjugular intrahepatic portosystemic shunt (TIPS). Stent under-dilation reduces HE, but a fixed diameter cannot be individualised to patient risk. An individualised scoring system tailoring balloon diameter to patient characteristics, without compromising efficacy or increasing variceal re-bleeding or stent dysfunction, is needed. METHODS: In this retrospective study, 717 patients with cirrhosis underwent TIPS with 8-mm covered stents between December 2015 and December 2023. Patients received conventional 8-mm full dilation (n = 408; before December 1, 2020) or individualised dilation (n = 309; from December 1, 2020 onward), with the balloon diameter (5-7 mm) chosen by an 11-factor scoring system. The primary endpoint was overt HE (West Haven grade II-IV) within 6 months. Propensity score matching, inverse probability weighting, Fine-Grey and E-value analyses were performed. RESULTS: Six-month overt HE was lower in the individualised group (14.6%; 45 of 309) than in the conventional group (27.5%; 112 of 408), yielding an absolute risk reduction of 12.9 percentage points (number needed to treat, 8; p < 0.001). After propensity score matching on 18 covariates (259 pairs), the conditional odds ratio was 0.42 (95% CI, 0.27-0.66; p < 0.001), consistent with inverse probability weighting (odds ratio, 0.47). Six-month re-bleeding (1.5% vs. 1.3%), stent dysfunction (3.9% vs. 4.2%) and ascites improvement (61.0% vs. 62.1%) did not differ significantly. CONCLUSIONS: An individualised balloon dilation strategy incorporating an 11-factor scoring system was associated with reduced post-TIPS HE, with no clear difference in variceal re-bleeding, stent dysfunction or ascites recurrence. TRIAL REGISTRATION: Chinese Clinical Trial Registry, ChiCTR2400087533.

Authors

Institutions

Publication Details

Journal
Liver International
Published
2026-11-17
DOI
https://doi.org/10.1111/liv.70992
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Individualised Versus Conventional Balloon Dilation for TIPS : Hepatic Encephalopathy in a Propensity‐Matched Before‐After Study

Jin‐Yuan Huang, Zhengguo Xu, Gui‐Ping Huang, Peng‐Cheng Ji et al.
Liver International
Liver Disease and Transplantation
article

Individualised Versus Conventional Balloon Dilation for TIPS : Hepatic Encephalopathy in a Propensity‐Matched Before‐After Study

Jin‐Yuan Huang, Zhengguo Xu, Gui‐Ping Huang, Peng‐Cheng Ji, Si‐Jie Hu, Wen‐Jun Luo, Yin Yang
article en

Abstract

BACKGROUND AND AIMS: Hepatic encephalopathy (HE) is a major complication of transjugular intrahepatic portosystemic shunt (TIPS). Stent under-dilation reduces HE, but a fixed diameter cannot be individualised to patient risk. An individualised scoring system tailoring balloon diameter to patient characteristics, without compromising efficacy or increasing variceal re-bleeding or stent dysfunction, is needed. METHODS: In this retrospective study, 717 patients with cirrhosis underwent TIPS with 8-mm covered stents between December 2015 and December 2023. Patients received conventional 8-mm full dilation (n = 408; before December 1, 2020) or individualised dilation (n = 309; from December 1, 2020 onward), with the balloon diameter (5-7 mm) chosen by an 11-factor scoring system. The primary endpoint was overt HE (West Haven grade II-IV) within 6 months. Propensity score matching, inverse probability weighting, Fine-Grey and E-value analyses were performed. RESULTS: Six-month overt HE was lower in the individualised group (14.6%; 45 of 309) than in the conventional group (27.5%; 112 of 408), yielding an absolute risk reduction of 12.9 percentage points (number needed to treat, 8; p < 0.001). After propensity score matching on 18 covariates (259 pairs), the conditional odds ratio was 0.42 (95% CI, 0.27-0.66; p < 0.001), consistent with inverse probability weighting (odds ratio, 0.47). Six-month re-bleeding (1.5% vs. 1.3%), stent dysfunction (3.9% vs. 4.2%) and ascites improvement (61.0% vs. 62.1%) did not differ significantly. CONCLUSIONS: An individualised balloon dilation strategy incorporating an 11-factor scoring system was associated with reduced post-TIPS HE, with no clear difference in variceal re-bleeding, stent dysfunction or ascites recurrence. TRIAL REGISTRATION: Chinese Clinical Trial Registry, ChiCTR2400087533.

Liver InternationalVol. 46(12)
Army Medical University (CN), Xinqiao Hospital (CN), First People's Hospital of Chongqing (CN)
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon